289 related articles for article (PubMed ID: 37696048)
21. Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.
Kesavardhana S; Varadarajan R
J Virol; 2014 Sep; 88(17):9590-604. PubMed ID: 24920800
[TBL] [Abstract][Full Text] [Related]
22. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
Ingale J; Tran K; Kong L; Dey B; McKee K; Schief W; Kwong PD; Mascola JR; Wyatt RT
J Virol; 2014 Dec; 88(24):14002-16. PubMed ID: 25253346
[TBL] [Abstract][Full Text] [Related]
23. Alternative substitutions of N332 in HIV-1
Jeffy J; Parthasarathy D; Ahmed S; Cervera-Benet H; Xiong U; Harris M; Mazurov D; Pickthorn S; Herschhorn A
mBio; 2024 Apr; 15(4):e0268623. PubMed ID: 38470051
[TBL] [Abstract][Full Text] [Related]
24. Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.
Schapiro HM; Khasnis MD; Ahn K; Karagiaridi A; Hayden S; Cilento ME; Root MJ
PLoS Pathog; 2022 May; 18(5):e1010531. PubMed ID: 35584191
[TBL] [Abstract][Full Text] [Related]
25. Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.
Kong L; Torrents de la Peña A; Deller MC; Garces F; Sliepen K; Hua Y; Stanfield RL; Sanders RW; Wilson IA
Acta Crystallogr D Biol Crystallogr; 2015 Oct; 71(Pt 10):2099-108. PubMed ID: 26457433
[TBL] [Abstract][Full Text] [Related]
26. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.
Wang Q; Zhang S; Nguyen HT; Sodroski J
J Virol; 2024 Feb; 98(2):e0159423. PubMed ID: 38289101
[TBL] [Abstract][Full Text] [Related]
28. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
J Virol; 2017 May; 91(10):. PubMed ID: 28250125
[TBL] [Abstract][Full Text] [Related]
29. Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
Tong T; D'Addabbo A; Xu J; Chawla H; Nguyen A; Ochoa P; Crispin M; Binley JM
PLoS Pathog; 2023 Aug; 19(8):e1011452. PubMed ID: 37549185
[TBL] [Abstract][Full Text] [Related]
30. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
[TBL] [Abstract][Full Text] [Related]
31. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
[TBL] [Abstract][Full Text] [Related]
32. Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.
Das R; Datta R; Varadarajan R
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817217
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
Kumar R; Ozorowski G; Kumar V; Holden LG; Shrivastava T; Patil S; Deshpande S; Ward AB; Bhattacharya J
J Biol Chem; 2017 Sep; 292(38):15849-15858. PubMed ID: 28743743
[TBL] [Abstract][Full Text] [Related]
34. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
[TBL] [Abstract][Full Text] [Related]
35. Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins.
Herschhorn A; Ma X; Gu C; Ventura JD; Castillo-Menendez L; Melillo B; Terry DS; Smith AB; Blanchard SC; Munro JB; Mothes W; Finzi A; Sodroski J
mBio; 2016 Oct; 7(5):. PubMed ID: 27795397
[TBL] [Abstract][Full Text] [Related]
36. Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer.
Mao Y; Wang L; Gu C; Herschhorn A; Désormeaux A; Finzi A; Xiang SH; Sodroski JG
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12438-43. PubMed ID: 23757493
[TBL] [Abstract][Full Text] [Related]
37. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein.
Nguyen HT; Madani N; Ding H; Elder E; Princiotto A; Gu C; Darby P; Alin J; Herschhorn A; Kappes JC; Mao Y; Sodroski JG
Virol J; 2017 Feb; 14(1):33. PubMed ID: 28209172
[TBL] [Abstract][Full Text] [Related]
39. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
[TBL] [Abstract][Full Text] [Related]
40. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
